DataMeds AI files draft information statement (Form PRE 14C)
DataMeds AI shareholders authorized an amendment to add 1,000,000 shares of blank-check preferred stock. Board gained flexibility to set terms for new preferred series, including voting, dividend, liquidation, conversion rights, restrictions. Plan includes designating 25,000 shares as Series A Convertible Preferred Sto